NewChem S.p.A.
Through the IN-SIlico molecular DEsign Laboratory (INSIDEL@b), CNR-IC provides the company NewChem
S.p.A. with ligand- and structure-based predictive models for bioactivity and toxicity predictions of drug
synthesis intermediates.
Through the IN-SIlico molecular DEsign Laboratory (INSIDEL@b), CNR-IC provides the company NewChem
S.p.A. with ligand- and structure-based predictive models for bioactivity and toxicity predictions of drug
synthesis intermediates.
